With a meaningful number of patients with diabetes experiencing vision loss from Diabetic Macular Edema (DME) at some point in their lives, it is reassuring to know that treatment with injection of VEGF inhibitor drugs such as Lucentis® and Eylea® Diabetic Macular Edema offer an excellent treatment option-even better that laser photocoagulation.
VEGF Inhibitor Injections for DME According to researchers reporting in the American Journal of Ophthalmology reviewing and publishing an analysis of studies on Diabetic Maculopathy published between January 1, 1985 and July 31, 2013, although laser photocoagulation has been the standard treatment for DME for nearly 3 decades, there is increasing evidence that better outcomes can be achieved with anti-Vascular Endothelial Growth Factor (anti-VEGF) injections. In fact, the number of patients with DME gaining an improvement of seeing an additional 10-15 letters on the eye chart was at least 2 times greater for those patients treated with the anti-VEGF injections as compared to being treated with laser treatments.
If you or someone you know has diabetes and is concerned about their risk of Diabetic Macular Edema (DME) or Diabetic Retinopathy, it is critical that they have regular dilated eye exams. Please call Eyecare Medical Group, 53 Sewall Street, Portland, Maine 04102 at 888-374-2020, visit Eyecare Medical Group, Google+ or facebook.com/eyecaremedicalgroup to schedule an appointment.